Endocrine-related cancer · 2026
The role of the B7 family in autoimmune thyroid diseases and thyroid cancer.
СтатьяОбзорНазвание и аннотация: Перевод пока не подготовлен
Обработка статьи · этапы, ошибки и управление
Загрузка состояния…
Ошибки и ограничения
История · было → стало
Состояние обновляется каждые 5 секунд, пока блок открыт. Процент показывается только там, где известен объём работы. Пауза останавливает продолжение этапа; текущий запрос к источнику может завершиться.
Zhang Ruidan, Che Yulu, Gong Yingying, Wang Yixuan, Fang Ziwen, Pan Zongfu
Аннотация
The B7 family exerts complex and diverse immunomodulatory effects on the occurrence and development of thyroid diseases. The abnormal expression and polymorphisms of B7 family molecules in autoimmune thyroid diseases result in the disruption of immune tolerance, activation of autoreactive T cells, and thyroid tissue damage. The dysfunction of the B7 family is also closely related to the progression of thyroid cancer (TC) through remodeling the tumor microenvironment and mediating immune evasion. Of note, targeting the B7 family has become a promising strategy for TC treatment. In addition, B7 family signaling linking to immune cell subsets, tertiary lymphoid structure formation, and therapeutic response are also discussed. With the emerging findings of B7 family members in thyroid diseases, understanding the comprehensive roles and mechanisms of B7 molecules would facilitate the clinical translation of B7-based immunotherapy.